Abstract
Data from well-designed, prospective clinical trials are lacking to support treatment of primary tumor in men diagnosed with metastatic prostate cancer. However, a growing body of evidence suggests that treatment of the primary tumor may enhance cancer control and survival in some men. This evidence is examined and recommendations are made for identifying patients with metastatic prostate cancer who may benefit from definitive treatment of the prostate tumor.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 183-189 |
| Number of pages | 7 |
| Journal | Current urology reports |
| Volume | 6 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 2005 |
Keywords
- Clin Oncol
- Localize Prostate Cancer
- Prostate Cancer
- Radiat Oncol Biol Phys
- Radical Prostatectomy
ASJC Scopus subject areas
- Urology
Fingerprint
Dive into the research topics of 'Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS